Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution

Abstract Background Interest in carbapenems has been rising in the last few years due to the emergence of drug resistant tuberculosis. Ertapenem (ETP), given once a day parenteral, and faropenem (FAR), oral, have a better administration profile than meropenem (MEM), imipenem (IPM) and doripenem (DOR...

Full description

Bibliographic Details
Main Authors: Ximena Gonzalo, Giovanni Satta, Julio Ortiz Canseco, Timothy D. McHugh, Francis Drobniewski
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Microbiology
Subjects:
Ertapenem
Faropenem
Mycobacterium tuberculosis
MDR-TB
XDR-TB
In-vitro
Online Access:http://link.springer.com/article/10.1186/s12866-020-01954-w

Internet

http://link.springer.com/article/10.1186/s12866-020-01954-w

Similar Items